Jennison Associates
XENT

Jennison Associates’s Intersect ENT, Inc XENT Stock Holding History

Jennison Associates’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-906,985
Closed -$15.5M – 747
2021
Q2 		$15.5M Sell
906,985
-9,013
-1% -$169K 0.01% 409
2021
Q1 		$19.1M Sell
915,998
-126,953
-12% -$2.93M 0.01% 362
2020
Q4 		$23.9M Buy
1,042,951
+35,182
+3% +$670K 0.02% 319
2020
Q3 		$16.4M Buy
1,007,769
+371,624
+58% +$6.73M 0.01% 324
2020
Q2 		$8.61M Sell
636,145
-256,580
-29% -$2.99M 0.01% 387
2020
Q1 		$10.6M Buy
892,725
+72,117
+9% +$1.6M 0.01% 329
2019
Q4 		$20.4M Buy
820,608
+232,765
+40% +$4.72M 0.02% 305
2019
Q3 		$10M Buy
587,843
+118,185
+25% +$2.15M 0.01% 398
2019
Q2 		$10.7M Buy
469,658
+381,857
+435% +$10.3M 0.01% 427
2019
Q1 		$2.82M Buy
+87,801
New +$2.72M ﹤0.01% 481
2018
Q4 		– Sell
-35,260
Closed -$1.01M – 737
2018
Q3 		$1.01M Sell
35,260
-1,277,160
-97% -$38.4M ﹤0.01% 558
2018
Q2 		$49.1M Sell
1,312,420
-362,332
-22% -$14.2M 0.05% 264
2018
Q1 		$65.8M Sell
1,674,752
-361,450
-18% -$13.2M 0.07% 215
2017
Q4 		$66M Buy
2,036,202
+372,320
+22% +$11.2M 0.07% 224
2017
Q3 		$51.8M Sell
1,663,882
-616,916
-27% -$18.3M 0.05% 266
2017
Q2 		$63.7M Sell
2,280,798
-34,072
-1% -$771K 0.07% 239
2017
Q1 		$39.7M Sell
2,314,870
-129,094
-5% -$1.81M 0.04% 311
2016
Q4 		$29.6M Buy
2,443,964
+22,786
+0.9% +$295K 0.03% 354
2016
Q3 		$38.4M Sell
2,421,178
-342,677
-12% -$5.16M 0.04% 316
2016
Q2 		$35.7M Sell
2,763,855
-30,951
-1% -$485K 0.04% 334
2016
Q1 		$53.1M Buy
2,794,806
+23,901
+0.9% +$433K 0.06% 266
2015
Q4 		$62.3M Buy
2,770,905
+279,176
+11% +$5.52M 0.06% 253
2015
Q3 		$58.3M Buy
2,491,729
+269,448
+12% +$7.44M 0.06% 271
2015
Q2 		$63.6M Buy
2,222,281
+959,008
+76% +$25.1M 0.06% 291
2015
Q1 		$32.6M Buy
1,263,273
+1,229,250
+3,613% +$28.1M 0.03% 394
2014
Q4 		$631K Sell
34,023
-1,036
-3% -$18.6K ﹤0.01% 685
2014
Q3 		$543K Buy
+35,059
New +$528K ﹤0.01% 687

Other funds holding XENT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates's XENT Position: Q3 2021 in Review

Jennison Associates sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 906,985 shares — an estimated $15.5M sold.

Jennison Associates first reported a position in XENT in Q3 2014 and held it in 27 quarters. The position peaked at $66M in Q4 2017. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Jennison Associates reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • Jennison Associates sold 906,985 Intersect ENT, Inc shares in Q3 2021, an estimated $15.5M.
  • Jennison Associates first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 27 quarters.
  • Jennison Associates's Intersect ENT, Inc position peaked at $66M in Q4 2017.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Jennison Associates's 13F filing for Q3 2021, filed 9 Nov 2021.